Clinical Trials · NCT00023829

Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Radiation Therapy Oncology Group
Enrollment
67
Start date
Aug 2001
Locations
1 site, Canada
Primary endpoint
Overall survival
View Gonadorelin compound reference